World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 5 July 2021
Main ID:  ACTRN12613000929707
Date of registration: 22/08/2013
Prospective Registration: Yes
Primary sponsor: Mater Health Service
Public title: Improving adherence with PEP (Positive end expiratory) chest physiotherapy in children with cystic fibrosis though the use of an electronic device, the PEP PT (Personal trainer)
Scientific title: Does the use of the PEP PT (a computer enhanced positive end expiratory chest physiotherapy device) in children with cystic fibrosis improve adherence with chest physiotherapy compared with standard PEP chest physiotherapy
Date of first enrolment: 01/10/2013
Target sample size: 36
Recruitment status: Withdrawn
URL:  https://anzctr.org.au/ACTRN12613000929707.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Other;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Dr Scott Burgesss   
Address:  Department of Respiratory and Sleep Medicine Mater Children's Hospital Raymond Terrace South Brisbane Q 4101 Australia
Telephone: 61 7 3163 8382
Email: scott.burgess@mater.org.au
Affiliation: 
Name: Dr Scott Burgess   
Address:  Department of Respiratory and Sleep Medicine Mater Children's Hospital Raymond Terrace South Brisbane QLD 4101 Australia
Telephone: 61 7 3163 8382
Email: scott.burgess@mater.org.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Cystic Fibrosis, using PEP and currently well.
Exclusion criteria: FEV1 less than 40% predicted

Age minimum: 4 Years
Age maximum: 16 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Human Genetics and Inherited Disorders - Cystic fibrosis
Respiratory - Other respiratory disorders / diseases
Cystic Fibrosis;
Cystic Fibrosis
Intervention(s)
The PEP Personal Trainer is a newly developed device which has been designed to provide both PEP (positive end expiratory pressure) chest physiotherapy and some key additional functions. A PEP mask is held to the face by the user. The user inhales gently through the mask and then exhales against resistance because of a one way valve and resistor. This provides pressure back down their airway. It is suggested that the subject reach and maintain 10-20cm water pressure for 3 seconds. This is a standard and well proven form of chest physiotherapy. During a session a user will normal perform 100 exhalations. The PEP PT measures the pressure associated with each blow using a electronic sensor contained within the mask. The PEP PT connects wirelessly to a tablet device. The key features of the device include: 1. An alarm to remind the subject to perform their PEP (typically done twice daily), 2. The screen displays the ideal pressure curve which the subject can follow to ensure an ideal technique, 3. The subject can play games on the device which again require and encourage an ideal technique (for example piloting a space ships which collects asteroids), 4. The device counts the number of blows performed and provides prompts and encouragement, 5. The devices scores each blow and assigns a point for each effective blow (PEP points) which the child's parent can redeem for rewards, 6. The device stores information about both adherence and technique which can be reviewed at consultations. In this trial subjects will be randomised to either the PEP PT or a control device which measures adherence and technique but does not connect to a screen or have the other features. The subjects use either device for 6 weeks. Subjects assigned to the control device then use the PEP PT for six w
Primary Outcome(s)
Adherence with chest physiotherapy as measured by the PEP device (for example if the patient is prescribed 100 blows in the morning and one hundred at night and they perform 100 blows in the morning and 50 at night, they will be assigned 100% adherence for the morning and 50% for the night).[6 weeks]
Secondary Outcome(s)
Technique with PEP. Each blow will be assessed against set criteria. The device will count the number of "good" blows. The number of "good" blows with the PEP PT compared to the control device with be the secondary outcome.[6 weeks]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
Golden Casket Grant, Mater Children's Hospital
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 01/07/2013
Contact:
Mater Health Services HREC
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history